Author

Michal Chovanec

Observed names: Chovanec Michal, Chovanec, Michal, M Chovanec, M. Chovanec, MICHAL CHOVANEC, Michal CHOVANEC, Michal Chovanec MUDr.

Observed institutions: Indiana University Health, Università Campus Bio-Medico, Slovak Medical University, Slovak Academy of Sciences, Universidad de Costa Rica, Národný Onkologický Ústav, Cancer Research Institute of the Slovak Academy of Sciences, National Cancer Institute, Biomedical Research Center of the Slovak Academy of Sciences, National Cancer Institute, National Cancer Institute, Hospital del Mar Research Institute, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indiana University, Comenius University Bratislava

ORCID: 0000-0002-5653-2909

Observed ORCID: 0000-0002-5653-2909

OpenAlex ID: A5009013764

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

2021 · Silke Gillessen, Nicolas Sauvé, et al. · Journal of Clinical Oncology · 253

PDF

Long-term toxicity of cisplatin in germ-cell tumor survivors

2017 · M. Chovanec, M. Abu Zaid, et al. · Annals of Oncology · 204

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

2021 · Jörg Beyer, Laurence Collette, et al. · Journal of Clinical Oncology · 178

PDF

Long-Term Cognitive Dysfunction in Cancer Survivors

2021 · Zuzana Országhová, Michal Mego, et al. · Frontiers in Molecular Biosciences · 176

PDF

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors

2015 · Z. Cierna, M. Mego, et al. · Annals of Oncology · 162

PDF

The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy

2022 · Aneta Sevcikova, Nikola Izoldova, et al. · International Journal of Molecular Sciences · 100

PDF

Advances in diagnosis and treatment of testicular cancer

2022 · Michal Chovanec, Liang Cheng · BMJ · 90

PDF

Systemic immune-inflammation index in germ-cell tumours

2018 · Michal Chovanec, Zuzana Cierna, et al. · British Journal of Cancer · 90

PDF

Late adverse effects and quality of life in survivors of testicular germ cell tumour

2021 · Michal Chovanec, Jakob Lauritsen, et al. · Nature Reviews Urology · 83

Phase II study of avelumab in multiple relapsed/refractory germ cell cancer

2019 · M. Mego, D. Svetlovska, et al. · Investigational New Drugs · 81

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors

2017 · C. Albany, N. Adra, et al. · Annals of Oncology · 81

Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors

2017 · Michal Chovanec, Zuzana Cierna, et al. · Oncotarget · 79

Clinical utility of plasma miR‐371a‐3p in germ cell tumors

2018 · Michal Mego, Ton van Agthoven, et al. · Journal of Cellular and Molecular Medicine · 70

PDF

Management of stage I testicular germ cell tumours

2016 · Michal Chovanec, Nasser Hanna, et al. · Nature Reviews Urology · 63

PARP expression in germ cell tumours

2013 · Michal Mego, Zuzana Cierna, et al. · Journal of Clinical Pathology · 60

Immunotherapy in Testicular Germ Cell Tumors

2020 · Katarina Kalavska, Silvia Schmidtova, et al. · Frontiers in Oncology · 56

PDF

Phase II study of everolimus in refractory testicular germ cell tumors

2015 · Michal Mego, Daniela Svetlovska, et al. · Urologic Oncology Seminars and Original Investigations · 53

Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity

2021 · Sona Ciernikova, Michal Mego, et al. · Cancers · 51

PDF

Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors

2018 · Michal Chovanec, Lucia Vasilkova, et al. · The Oncologist · 49

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells

2019 · Silvia Schmidtova, Katarina Kalavska, et al. · Cancers · 46

PDF

Overcoming Chemotherapy Resistance in Germ Cell Tumors

2022 · Zuzana Országhová, Katarina Kalavska, et al. · Biomedicines · 42

PDF

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness

2020 · Silvia Schmidtova, Lambert C. J. Dorssers, et al. · Cancer Cell International · 37

PDF

Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: a review

2023 · Petra Chalova, Anton Tazky, et al. · Frontiers in Oncology · 35

PDF

Immune mechanisms and possible immune therapy in testicular germ cell tumours

2019 · M. Chovanec, J. Mardiak, et al. · Andrology · 31

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours

2020 · Zuzana Cierna, Vera Miskovska, et al. · BMC Cancer · 30

PDF

Works count: 217

Citation count: 3,056

H-index: 27

I10-index: 53